PDCD1 and Skin rash: To begin, subgroup analysis would be used to assess the difference in rash risk between the PD-1 and PD-L1 subgroups; second, the effect of different administration timing on rash would be assessed; and then, detailed subgroup analysis would be used to elucidate the source of heterogeneity.